PG4 not checked
Pfizer · PG4 in Buffer · PG4 Multivalent Vaccine
FollowEvery change as it happens, and a Monday email
Trials
6 active
7 in total · 2 in the EU
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Pneumococcal Disease (5 trials), Streptococcus Pneumoniae
- Main trialPhase 3
- “The purpose of this study is to provide safety data and demonstrate lot consistency with the PG4 vaccine by evaluating the immunogenicity of 3 different lots of this vaccine. This study will compare a new pneumococcal vaccine with the vaccine currently in use to see if they are similarly safe. It will also compare three batches of the new vaccine to make sure they work the same way. Blood samples will be taken to measure how the body responds to the vaccines. The study will be conducted in the United States. Participants will be assigned to 1 of 4 groups. Group 1: PG4 vaccine lot 1; Group…”In the company’s words, NCT07794748 on ClinicalTrials.gov
- Other names
- PG4 in Buffer · PG4 Multivalent Vaccine · PG4 lot 1 · PG4 Lot 2 · PG4 Lot 3 · PG4 vaccine in Buffer
Other drugs for Pneumococcal Disease
- 13-Valent Pneumococcal Polysaccharide Conjugate VaccineCanSino Biologics Inc. · Phase 3
- 20vPCVSanofi · Phase 3
- Pneumococcal Conjugate VaccineSanofi · Phase 3
- Pneumococcal conjugate vaccinePfizer · Phase 3
- PrevnarPfizer · Phase 3
- 20vPCV licensed vaccineSanofi · Phase 3
Coming up6
- 4 Mar 2027Phase 2 trial completes · ClinicalTrials.gov
- 26 Apr 2027Phase 3 trial completes · ClinicalTrials.gov
- 21 Oct 2027Phase 1 trial completes · ClinicalTrials.gov
- 2 Dec 2027Phase 3 trial completes · ClinicalTrials.gov
- 30 Dec 2028Phase 3 trial completes · ClinicalTrials.gov
- 5 Jun 2029Phase 3 trial completes · ClinicalTrials.gov
Changes2
Last 90 days- 12 NovStatus changed: Recruiting to Active, not recruiting · ClinicalTrials.gov NCT07794748
- 12 NovCompletion date moved: 2027-06-07 to 2027-04-26 · ClinicalTrials.gov NCT07794748
Trials7
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Active, not recruiting | 26 Apr 2027 | A Study to Assess the Safety, Tolerability, and Immunogenicity of 3 Lots of a Multivalent Pneumococcal Conjugate Vaccine Administered to Adults | |
| Phase 3Recruiting | 2 Dec 2027 | Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents | |
| Phase 3Recruiting | 30 Dec 2028 | A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants | |
| Phase 3Recruiting | 5 Jun 2029 | A Study to Learn About How a New Pneumococcal Vaccine Works in Infants. | |
| Phase 2Active, not recruiting | 4 Mar 2027 | A Study to Learn About How a New Pneumococcal Vaccine Works in Infants | |
| Phase 1Active, not recruiting | 21 Oct 2027 | A Study to Learn About How a New Pneumococcal Vaccine Works in Adults | |
| Phase 2Completed | 9 Feb 2026 | A Study to Learn About How a New Pneumococcal Vaccine Works in Children |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026